Larimar Therapeutics Inc. (LRMR)
LRMR trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$2.16
-14.63% on the day
Market cap
$224.4M
Micro cap
Revenue
No annual revenue filed since the period ending 2019-12-31
Net income
No annual revenue filed since the period ending 2019-12-31
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | LRMR on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2014 |
| SEC CIK | 0001374690 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials
No annual revenue filed since the period ending 2019-12-31.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-02-26 |
| Latest annual report | 10-K | 2026-03-19 |
| Latest quarterly / interim | 10-Q | 2026-08-04 |
| Latest current report | 8-K | 2026-09-29 |
| Latest proxy | DEF 14A | 2026-04-20 |
Source: SEC EDGAR submissions feed, 696 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| NATR | Nature's Sunshine Products Inc. | $12.76 | +0.39% | $224.5M |
| SLGL | Sol-Gel Technologies Ltd. | $68.30 | -5.66% | $223.6M |
| KROS | Keros Therapeutics Inc. | $11.23 | -3.27% | $222.7M |
| ZNTL | Zentalis Pharmaceuticals Inc. | $2.40 | -4.76% | $227.2M |
| GLSI | Greenwich LifeSciences Inc. | $15.50 | -12.77% | $227.5M |
| SIGA | SIGA Technologies Inc. | $3.08 | -2.53% | $221.3M |
| PYXS | Pyxis Oncology Inc. | $1.85 | -7.96% | $221.2M |
| IFRX | InflaRx N.V. | $1.55 | -2.52% | $228.4M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier